Exentis uses advanced 3D printing to produce pharmaceutical tablets with customizable release profiles, ensuring precise drug delivery and enhancing patient comfort and treatment efficacy. Exentis’ technology can produce over 200 million tablets annually on a single production system, accommodating multiple active ingredients and excipients per tablet.
Exentis also integrates QR codes onto tablets during mass production for easy tracking and verification, benefiting conditions like diabetes, Parkinson’s disease, and epilepsy to name a few.
Tablet formulations include:
- Oral release (in a few seconds)
- Immediate release (in approx. 20 minutes)
- Extended release (over 6 hours)
These options cater to various therapeutic needs.